Back to top
more

QuidelOrtho (QDEL)

(Real Time Quote from BATS)

$43.92 USD

43.92
79,313

-0.20 (-0.45%)

Updated Sep 11, 2024 11:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 25.71% and 0.70%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

QuidelOrtho (QDEL) Reports Solid Preliminary Q4 Revenues

QuidelOrtho's (QDEL) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.

QuidelOrtho's (QDEL) Myocardial Infarction Test Cleared in Canada

QuidelOrtho's (QDEL) TriageTrue hsTnl Test is to be used to diagnose myocardial infarction following Health Canada's approval.

QuidelOrtho's (QDEL) Latest JV to Boost Footprint in China

QuidelOrtho's (QDEL) new JV will likely translate into a faster time-to-market and a more compelling menu for VITROS assays in support of its growth strategy in China and beyond.

Are Investors Undervaluing PetIQ (PETQ) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Eagle Pharmaceuticals (EGRX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights Boyd Gaming, Expeditors International of Washington, QuidelOrtho, LPL Financial and Cboe Global Markets

Boyd Gaming, Expeditors International of Washington, QuidelOrtho, LPL Financial and Cboe Global Markets have been highlighted in this Screen of The Week article.

Swayta Shah headshot

5 Stocks With Solid Sales Growth to Fight Economic Slowdown

Sales growth is vital for the survival of a business, even during an economic slowdown. Let's check Boyd Gaming (BYD), Expeditors International (EXPD), QuidelOrtho (QDEL), LPL Financial (LPLA) and Cboe Global (CBOE), which are recording top-line growth.

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

QuidelOrtho (QDEL) Crossed Above the 20-Day Moving Average: What That Means for Investors

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

Zacks.com featured highlights include Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors

Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors are part of the Zacks Screen of the Week article.

Swayta Shah headshot

5 Stocks With Solid Sales Growth to Navigate Volatile Markets

Sales growth is vital for the survival of a business, even during an economic slowdown. Let's check Crocs (CROX), Unum (UNM), QuidelOrtho (QDEL), LPL Financial (LPLA) and Clean Harbors (CLH), which are witnessing top-line growth.

Indrajit Bandyopadhyay headshot

3 Medical Products Stocks Navigating Industry Challenges (Revised)

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. QDEL, LNTH and TGTX are well-poised to gain from the favorable factors.

Is QuidelOrtho (QDEL) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Industry Outlook Highlights QuidelOrtho, Lantheus and TG Therapeutics

QuidelOrtho, Lantheus and TG Therapeutics are part of Zacks Industry Outlook article.

Indrajit Bandyopadhyay headshot

3 Medical Products Stocks Navigating Industry Challenges

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. QDEL, LNTH and TGTX are well-poised to gain from the favorable factors.

Are Investors Undervaluing PetIQ (PETQ) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights Conagra, Cboe Global Markets, QuidelOrtho, American Electric Power Company and Clean Harbors

Conagra, Cboe Global Markets, QuidelOrtho, American Electric Power Company and Clean Harbors have been highlighted in this Screen of The Week article.

Swayta Shah headshot

5 Stocks With Robust Sales Growth to Combat Recession Fears

Sales growth is vital for the survival of a business, even during an economic slowdown. Let's check Conagra Brands (CAG), Cboe Global Markets (CBOE), QuidelOrtho (QDEL), American Electric Power (AEP) & Clean Harbors (CLH) that are recording top-line growth.

QuidelOrtho (QDEL) Q3 Earnings Top Estimates, 2022 View Revised

QuidelOrtho's (QDEL) robust results in POC and Donor Screening product lines drives its third-quarter 2022 top line.

Is Eagle Pharmaceuticals (EGRX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

QuidelOrtho (QDEL) Reports Solid Preliminary Q3 Revenues

QuidelOrtho's (QDEL) revenue growth in the third quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.